WHO lists 9th COVID-19 vaccine for emergency use with aim to increase access to vaccination in lower-income countries

author-image
New Update
WHO lists 9th COVID-19 vaccine for emergency use with aim to increase access to vaccination in lower-income countries


By a staff reporter: 

Today, the World Health Organization issued an emergency use listing (EUL) for NVX-CoV2373, expanding the basket of WHO-validated vaccines against the SARS-CoV-2 virus. The vaccine, named CovovaxTM, is produced by the Serum Institute of India under licence from Novavax and is part of the COVAX facility portfolio, giving a much-needed boost to ongoing efforts to vaccinate more people in lower-income countries.
WHO’s EUL procedure assesses the quality, safety and efficacy of COVID-19 vaccines and is a prerequisite for COVAX vaccine supply. It also allows countries to expedite their own regulatory approval to import and administer COVID-19 vaccines.